(Q48222344)

http://europepmc.org/abstract/MED/29183235

9 February 2018

title

Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age. (English)

1 reference

http://europepmc.org/abstract/MED/29183235

9 February 2018

main subject

pneumococcal conjugate vaccine

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Raul E Isturiz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Cassandra Hall-Murray

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

John M McLaughlin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Vincenza Snow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Chris Webber

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Allison Thompson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Daniel A Scott

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

29 November 2017

1 reference

http://europepmc.org/abstract/MED/29183235

9 February 2018

published in

Expert Review of Vaccines

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

45-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Rates of pneumococcal disease in adults with chronic medical conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Efficacy of pneumococcal vaccination in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Determining the optimal pneumococcal vaccination strategy for adults: is there a role for the pneumococcal conjugate vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Effectiveness of pneumococcal polysaccharide vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Clinical and economic burden of pneumococcal disease in older US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Pneumococcal infection in adults: burden of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Experiencing simulated aging improves knowledge of and attitudes toward aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Preventing pneumococcal infections in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Use of pneumococcal vaccine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Pneumococcal conjugate vaccines for adults: reasons for optimism and for caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

Rethinking number-needed-to-vaccinate for pneumococcal conjugate vaccines in older adults: Current and future implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2018.1411196

10.1080/14760584.2018.1411196

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29183235%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference